<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="70527">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01946841</url>
  </required_header>
  <id_info>
    <org_study_id>LRD - 2013 - ALENPHED</org_study_id>
    <nct_id>NCT01946841</nct_id>
  </id_info>
  <brief_title>Specific Enteral Nutrition in Malnourished, Dialysis Patients With Chronic Kidney Disease. Efficacy, Safety, Quality of Life</brief_title>
  <acronym>AL-EN-PHED</acronym>
  <official_title>Effets de la Nutrition entérale spécifique RealDiet®Renal (NES) Chez Des Patients Insuffisants rénaux hémodialysés dénutris : efficacité, tolérance, qualité de Vie.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lactalis</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Clinact</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Lactalis</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <authority>France: Committee for the Protection of Personnes</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this unblinded study is to assess the nutritional effects of a 12 weeks
      administration of the specific enteral nutrition (SEN) RealDiet®Renal pockets, as well as
      the impact on the patients' quality of life.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">January 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Evolution of serum prealbumin and albumin.</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Evaluate during 3 months specific enteral nutrition (SEN) treatment, and 3 months after treatment interruption, the effects of the study product on the evolution of serum prealbumin and albumin.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evolution of nutritional status during 3 months of enteral nutrition, and during 3 months after end of treatment.</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evolution of quality of life during 3 months of enteral nutrition, and during 3 months after end of treatment.</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evolution of tolerance of study product during 3 months of enteral nutrition.</measure>
    <time_frame>3 mois</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <condition>Renal Failure Chronic Requiring Hemodialysis</condition>
  <condition>Severe Malnutrition</condition>
  <condition>Tolerance</condition>
  <condition>Quality of Life</condition>
  <condition>Activity</condition>
  <condition>Appetite and General Nutritional Disorders</condition>
  <arm_group>
    <arm_group_label>RealDiet®Renal enteral nutrition</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>RealDiet®Renal</intervention_name>
    <arm_group_label>RealDiet®Renal enteral nutrition</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic kidney disease patient on hemodialysis for at least 3 months, with a minimum
             of three hemodialysis sessions of 4 hours per week

          -  Patients aged 18 years

          -  Written, free and informed consent given by the Patient

          -  Patient insured under the social security system or equivalent

          -  Patients who did not receive enteral nutrition during the 3 months preceding
             inclusion ; taking an oral nutritional supplement, or per-dialytic parenteral
             nutrition or total parenteral nutrition is not a criterion of non-inclusion

          -  Patient in a state of malnutrition

               -  defined by the presence of at least 3 out of 5 of the following criteria :

                    -  weight loss greater than 10% observed in the last six months

                    -  serum albumin &lt;35 g / l

                    -  serum Prealbumin &lt;300 mg / l

                    -  BMI &lt;20

                    -  NPNA &lt;1 g / kg / day for 2 consecutive months

        and

          -  presenting

               -  food intake &lt;20 kcal / kg / day or

               -  failure of other nutritional care methods, namely, oral nutritional supplements
                  and / or peridialytic parenteral nutrition, or total parenteral nutrition

               -  lack of compliance after one month, to the nutritional care methods mentioned
                  above. • Patients for whom the decision to prescribe enteral feeding was
                  previously taken

        Exclusion Criteria:

          -  Patients with a history of intolerance to enteral feeding

          -  Index Kt/Veq (balanced) &lt; or = 1.2 or index Kt/Vsp (single pool) &lt; or = 1.4 according
             to the method used

          -  Patients with a disease compromising the short-term (4-6 months) prognosis (cancer or
             other disease in the terminal phase)

          -  Pregnant Patient

          -  Patient with a known allergy to at least one of the following : milk protein, soy,
             fish

          -  Patient whose digestive tract is not functional or patient in shock

          -  Patient protected under guardianship

          -  Patient in exclusion period after participation in another clinical trial.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jacqueline Brasy</last_name>
    <phone>+33 299475084</phone>
    <email>jacqueline.brasy@lactalis.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pascale Le Ruyet</last_name>
    <phone>+33 299475099</phone>
    <email>pascale.leruyet@lactalis.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Lactalis</name>
      <address>
        <city>Retiers</city>
        <zip>35240</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacqueline Brasy</last_name>
      <phone>+33299475084</phone>
      <email>jacqueline.brasy@lactalis.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 17, 2013</lastchanged_date>
  <firstreceived_date>August 6, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic kidney disease</keyword>
  <keyword>Hemodialysis</keyword>
  <keyword>Severe malnutrition</keyword>
  <keyword>Enteral nutrition</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
    <mesh_term>Nutrition Disorders</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Malnutrition</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
